Clinical trial
An Open-label, Multicentre, Randomised, Single-period, Parallel Design Study to Assess the Effect of Closed Loop Insulin Delivery From Onset of Type 1 Diabetes in Youth on Residual Beta Cell Function Compared to Standard Insulin Therapy
NCT02871089 is registered in ClinicalTrials.gov with University of Cambridge as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label, Multicentre, Randomised, Single-period, Parallel Design Study to Assess the Effect of Closed Loop Insulin Delivery From Onset of Type 1 Diabetes in Youth on Residual Beta Cell Function Compared to Standard Insulin Therapy
- Lead sponsor
- University of Cambridge
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 31, 2017
- Completion date
- July 31, 2024
- Enrollment
- 96 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus, type 1 diabetes